This public procurement record has 3 releases in its history.

Award

10 Nov 2026 at 10:06

Award

28 Oct 2026 at 17:56

Award

28 Oct 2026 at 17:20

Summary of the contracting process

Western Health & Social Care Trust procured the supply of Eylea (aflibercept) 40 mg/ml solution for injection in pre-filled syringes. This is a pharmaceutical product for patients already receiving Eylea under established treatment regimens. The supply maintains treatment continuity while clinicians assess whether to introduce a contracted aflibercept biosimilar, and consider any switching strategy and implementation decisions. The requirement is for the Western Trust’s clinical services, with delivery in Northern Ireland. The product is a branded medicine rather than a general supply of injectable medicines, so suppliers focused on this specific treatment and its continuity-of-supply needs are the closest fit.

The procurement is complete and the contract has been awarded to Bayer Public Limited Company. The Trust used a direct award, citing continuity of patient care while it reviews the potential introduction of a contracted biosimilar comparator and any patient switching arrangements. The award was made on 27 October 2026 and the contract was signed that day. The contract runs from 10 November 2026 to 30 April 2027. Its value is £175,267.59 excluding VAT (£210,321.11 including VAT). There is one lot, covering the supply of Eylea in pre-filled syringes. No competitive evaluation criteria are set out; the procurement rationale was to maintain existing treatment regimens pending clinical review and approval of any switching strategy.

For suppliers competing when this specific requirement returns to market, credibility will depend on being able to supply aflibercept in the required pre-filled syringe presentation and to support uninterrupted treatment for established patients. The buyer’s stated rationale shows that dependable supply assurance and the ability to maintain existing clinical regimens during a transition are central considerations, alongside the medicine itself. A supplier of a biosimilar comparator would need evidence relevant to the Trust’s clinical assessment and any approved switching strategy; the current requirement was explicitly for branded Eylea while that assessment was pending. This is a focused pharmaceutical supply opportunity for manufacturers or authorised suppliers with the product, distribution capacity and reliability to serve the Western Trust’s patient need.

How relevant is this notice?

Notice Information

Notice Title

EYLEA 3.6MG/90MICROLITRE SOLUTION FOR INJECTION

Notice Description

Supply of Eylea Brand of AFLIBERCEPT 40 mg/ml solution for injection in pre-filled syringe to meet clinical need in the Western Trust until 30/04/2027.

Procurement Information

Continuity of patient care is required whilst clinicians complete assessment of the potential introduction of the contracted aflibercept biosimilar comparator. Established patients are currently treated with Eylea under existing treatment regimens. Continued supply of Eylea is required pending completion of clinical review, approval of any switching strategy, and implementation decisions.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0792e0
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/106519-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£175,267 £100K-£500K
Contracts Value
£175,267 £100K-£500K

Notice Dates

Publication Date
10 Nov 20266 days ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
27 Oct 20263 weeks ago
Contract Period
10 Nov 2026 - 30 Apr 2027 1-6 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Western Health and Social Care Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDONDERRY
Postcode
BT47 6SB
Postcode Area
Northern Ireland
Country
Northern Ireland

Major Region (ITL 1)
TLN Northern Ireland
Basic Region (ITL 2)
TLN0 Northern Ireland
Small Region (ITL 3)
TLN0A Derry City and Strabane
Delivery Location
Not specified

Local Authority
Derry City and Strabane
Electoral Ward
Kilfennan
Westminster Constituency
Foyle

Supplier Information

Number of Suppliers
1
Supplier Name

Bayer Plc

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...